Daniel R. Passeri
2020 - Cue Biopharma
In 2020, Daniel R. Passeri earned a total compensation of $5.8M as Chief Executive Officer at Cue Biopharma, a 387% increase compared to previous year.
Compensation breakdown
| Bonus | $244,625 |
|---|---|
| Option Awards | $2,246,235 |
| Salary | $501,154 |
| Stock Awards | $2,844,000 |
| Other | $5,772 |
| Total | $5,841,786 |
Passeri received $2.8M in stock awards, accounting for 49% of the total pay in 2020.
Passeri also received $244.6K in bonus, $2.2M in option awards, $501.2K in salary and $5.8K in other compensation.
Rankings
In 2020, Daniel R. Passeri's compensation ranked 1,816th out of 13,090 executives tracked by ExecPay. In other words, Passeri earned more than 86.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,816 out of 13,090 | 86th |
Division Manufacturing | 699 out of 5,621 | 88th |
Major group Chemicals And Allied Products | 251 out of 2,254 | 89th |
Industry group Drugs | 210 out of 1,954 | 89th |
Industry Pharmaceutical Preparations | 149 out of 1,459 | 90th |
Source: SEC filing on April 26, 2021.
Passeri's colleagues
We found two more compensation records of executives who worked with Daniel R. Passeri at Cue Biopharma in 2020.